Hyderabad Telangana, India

Bethi Sridhar Reddy


Average Co-Inventor Count = 19.0

ph-index = 1


Location History:

  • Hyberabad, IN (2001)
  • Hyderabad, IN (2002 - 2003)

Company Filing History:


Years Active: 2001-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Bethi Sridhar Reddy

Introduction

Bethi Sridhar Reddy is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of chemistry, particularly in the development of cyclic oxygen compounds. With a total of 3 patents to his name, Reddy's work has implications for pharmaceutical compositions and therapeutic methods.

Latest Patents

Reddy's latest patents focus on substituted oxygen alicyclic compounds, including methods for their synthesis. The inventions provide new methods for the preparation of cyclic oxygen compounds, such as 2,5-disubstituted tetrahydrofurans, 2,6-disubstituted tetrahydropyrans, 2,7-disubstituted oxepanes, and 2,8-oxocanes. These innovations also introduce new cyclic oxygen compounds and pharmaceutical compositions that incorporate these compounds, showcasing Reddy's commitment to advancing medicinal chemistry.

Career Highlights

Throughout his career, Reddy has worked with prominent companies in the pharmaceutical industry, including Millennium Pharmaceuticals Limited and Millennium Pharmaceuticals, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Reddy has collaborated with notable coworkers such as Mukund Shankar Chorghade and Mukund Keshao Gurjar. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Bethi Sridhar Reddy's contributions to the field of chemistry through his innovative patents highlight his role as a significant inventor. His work on cyclic oxygen compounds not only advances scientific knowledge but also has the potential to improve therapeutic methods in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…